Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 6/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 11/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 9/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13794393 | 0.85 | MCHR1 (0.49) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13793895 | 0.85 | MCHR1 (0.57) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13797103 | 0.84 | NPY5R (0.69) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13794305 | 0.84 | MCHR1 (0.56) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13797200 | 0.83 | NPY5R (0.55) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13794668 | 0.83 | NPY5R (0.49) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13793870 | 0.82 | MCHR1 (0.60) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13794297 | 0.82 | MCHR1 (0.58) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13794300 | 0.82 | MCHR1 (0.58) | NPY5RMCHR1ADRA2AHTR1AADRA1A | |
| SCHEMBL13794282 | 0.81 | MCHR1 (0.57) | NPY5RMCHR1ADRA2AHTR1AADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544690-B2 | MCH receptor antagonists | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7544690-B2 | MCH receptor antagonists | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-20070037836-A1 | Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037836-A1 | Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide | MCHR1, MCHR2, MC4R | NPY5R 11/4885MCHR1 1/4885ADRA2A 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.